文献速递免疫规划传染病防控与疫情报告

鼻内免疫表达S1抗原可对小鼠提供功能性无菌保护抵抗SARS-CoV-2攻击

Intranasal immunization expressing S1 antigen can confer functionally sterile protection against an intranasal SARS-CoV-2 challenge in mice.
PubMed 文献 · Vaccine · 2026-10-14

研究用表达SARS-CoV-2 S1结构域(融合T4 fibritin三聚化结构域)的仙台病毒载体对BALB/c小鼠进行鼻内免疫,检测到血浆和支气管肺泡灌洗液(BALF)中和抗体;经小鼠适应株QHmusX鼻内攻击后,未免疫小鼠全部体重显著下降且BALF病毒载量高,而鼻内免疫小鼠除一只sgRNA微量外BALF未检出病毒sgRNA或感染性病毒且无体重下降。

要点

  • 鼻内免疫可诱导血浆和BALF中和抗体。
  • 免疫小鼠攻击后BALF未检出病毒sgRNA或感染性病毒(一只微量)。
  • 免疫小鼠无体重下降,未免疫小鼠全部体重显著下降。

核心结论

  • 鼻内免疫表达S1抗原可对小鼠提供功能性无菌保护抵抗SARS-CoV-2感染。

研究设计与样本

  • 在BALB/c小鼠模型中研究表达SARS-CoV-2 S抗原的鼻内免疫预防SARS-CoV-2感染。
  • 使用表达SARS-CoV-2 S1结构域融合T4 fibritin三聚化结构域的仙台病毒载体进行鼻内免疫。
  • 鼻内攻击使用小鼠适应SARS-CoV-2株QHmusX;未免疫小鼠n=9,鼻内免疫小鼠n=8。

主要发现

  • 鼻内免疫在血浆和BALF中诱导中和抗体。
  • 攻击后未免疫小鼠(n=9)全部体重显著下降且BALF病毒载量高。
  • 鼻内免疫小鼠(n=8)BALF未检出病毒sgRNA或感染性病毒,除一只小鼠sgRNA微量,且无体重下降。

临床怎么用

  • 提示鼻内免疫策略可能有助于诱导黏膜免疫以阻断SARS-CoV-2传播。

局限性

  • 研究仅在小鼠模型中进行,结果外推到人需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Currently approved COVID-19 vaccines have shown significant protective efficacy against disease onset and progression after SARS-CoV-2 infection. However, systemic immune responses induced by intramuscular vaccination have limited impact on protection of viral transmission. Intranasal vaccination is an important strategy for induction of mucosal immune responses for protection of viral transmission. Here, we investigated the potential of intranasal immunization expressing a SARS-CoV-2 spike (S) antigen to prevent SARS-CoV-2 infection in a mice model. Intranasal immunization with a Sendai virus vector expressing SARS-CoV-2 S1 domain fused with the trimerization domain of T4 fibritin induced neutralizing antibodies detected not only in plasma but also in bronchoalveolar lavage fluid (BALF) in BALB/c mice. After an intranasal challenge with a mouse-adapted SARS-CoV-2 strain QHmusX, all the unimmunized mice (n = 9) showed significant body weight loss and high viral load in BALF. In contrast, the intranasally-immunized mice (n = 8) had no detectable viral sgRNA nor infectious viruses in BALF except for one mouse with marginal level of sgRNA, showing no body weight loss. This study indicates that intranasal immunization expressing S1 antigen can confer functionally sterile protection against SARS-CoV-2 infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ishii H, Miyauchi K, Harada S, et al. Intranasal immunization expressing S1 antigen can confer functionally sterile protection against an intranasal SARS-CoV-2 challenge in mice. Vaccine. 2026. PMID: 42874153. doi:10.1016/j.vaccine.2026.129259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。